International Journal of Medical Science and Clinical Invention https://valleyinternational.net/index.php/ijmsci <p>Welcome to the International Journal of Medical Science and Clinical Invention (IJMSCI). Our journal is dedicated to publishing cutting-edge research and innovative clinical advancements in the field of medical science.</p> <p>Our mission is to serve as a platform for researchers, clinicians, and healthcare professionals to disseminate their findings and share their expertise with the global community. IJMSCI provides a wide-ranging and interdisciplinary forum for the exchange of ideas and information in the areas of medical science, clinical practice, and invention.</p> <p>We publish original research articles, review articles, case reports, and short communications in all areas of medical science and clinical invention, including but not limited to, internal medicine, surgery, pediatrics, obstetrics and gynecology, dermatology, orthopedics, neurology, and oncology.</p> <p>At IJMSCI, we strive to maintain the highest standards of quality and rigor in our publishing process. Our editorial board comprises experts from leading medical institutions worldwide, and our peer-review process ensures that only the most relevant, novel, and impactful research is published.</p> <p>We welcome submissions from researchers and clinicians around the world and encourage you to share your work with us. If you have any questions or need assistance, our editorial team is here to help.</p> <p>Join the global community of medical science and clinical invention experts and stay ahead of the curve with IJMSCI!</p> Valley International Journals en-US International Journal of Medical Science and Clinical Invention 2348-991X Retrospective Study of Various Factors In Pediatric To Severe Dengue Infection https://valleyinternational.net/index.php/ijmsci/article/view/4713 <p><strong>Introduction: </strong>Dengue epidemics are known to have occurred over the last three centuries in tropical, subtropical and temperate areas of the world. Annually a 100 million cases of Dengue fever and half a million cases of dengue hemorrhagic fever (DHF) occur in the world with a case fatality in Asian countries of 0.5%–3.5%. <strong> Objective:</strong> To assess the various factors in pediatric to severe dengue infection. <strong>Methods: </strong>A hospital-based Retrospective study was conducted at Department Of Paediatric, Mugda Medical College Hospital, Dhaka, Bangladesh from October to December 2023. Number of patients included in the study was 50. In children with high degree clinical suspicion of Dengue infection NS 1 antigen (who came within first 48 hours of fever) and/or Dengue antibody IgM, IgG (who came after five days of fever) were performed. Positive Dengue cases were taken written informed consent &amp; interviewed on the risk factors of Dengue infection. Data related to patients demography, risk factors, clinical presentation, pattern of Dengue infection and outcome were documented on the pre-structured questionnaire. <strong>Results</strong>: The study was enrolled 100 patients of suspected dengue fever of whom 50 (50.0%) were serologically confirmed to have dengue infection. 30 (60%) patients were males and 20 (40%) were females. 38 (76%) patients had classic dengue fever while 12 (24%) fulfilled the criteria of dengue hemorrhagic fever. Of those patients with dengue hemorrhagic fever, 6 patients had developed dengue shock syndrome. Among the study 44 (88%) from urban and 6 (12%) rural area patients. All cases and is the most common symptom followed by headache, myalgia, vomiting etc. Hemorrhagic manifestations were seen that included petechiae, ecchymosis, gum bleeding, hematuria, malena, hematemesis and epistaxis. Most common complicationswere hepatic dysfunction, renal failure, multi organ failure, encephalopathy and ARDS. Among 50 suspected dengue cases 38 (76.0%) cases were serologically dengue positive. Among the 38 serologically dengue positive patients 17 (44.7%) were NS1 antigen positive, 13 (34.2%) IgM antibodies and 8(21.0%) both IgM and IgG antibodies positive. The distribution of the serologically dengue positive patients out of 50 clinically suspected cases.<strong> Conclusion</strong>: Dengue is one amongst the key causes of dedifferentiated fever. It presents as an extremely broad wellness and is hardly recognized as a clinical entity by primary health care physicians. This study highlights the practician the importance of break bone fever to clinicians within the areas of medical specialty, manifestations, complications and outcome of the wellness</p> Mohammad Sazzad Hossain Chowdhury Md. Obaidul Islam Md. Asaduzzaman Copyright (c) 2024 International Journal of Medical Science and Clinical Invention https://creativecommons.org/licenses/by/4.0/ 2024-04-04 2024-04-04 11 04 7081 7086 10.18535/ijmsci/v11i4.01 Topical application of vitamin D cream in particiants with inflammatory acne due to vitamin D deficiency https://valleyinternational.net/index.php/ijmsci/article/view/4727 <p>Acne vulgaris (AV) represents a chronic inflammatory condition affecting pilosebaceous units, characterized by a multifactorial etiology. AV can manifest as both inflammatory and non-inflammatory skin lesions. Non-inflammatory acne is termed a comedone, which can be either closed (whiteheads) or open (blackheads). Inflammatory acne encompasses papules, pustules, nodules, and pseudocysts. The most common regions for acne occurrence are the facial region (90%), thoracic area (14%), and dorsal region (60%).&nbsp; In the study involving transdermal application of vitamin D cream (applied twice daily; morning and evening) in subjects with inflammatory acne due to vitamin D deficiency, 33 participants took part, comprising 8 males and 25 females. The age group most affected was 18-25 years (adolescent age), followed by a lesser impact in the 26-30 age group, and the lowest incidence observed in the late 36-45 age group. Among males, facial and thoracic regions were most affected by inflammatory acne (37.5%), while among females, the facial region showed a higher percentage of 54%, and the thoracic area was at 40%, with a minimal impact on the dorsal region (M=25%; F=8%). Reductions in inflammatory acne ranged from 100% to 10%, with substantial improvements noted in the male population, achieving 100% and 80% reduction (100% reduction: facial region 25%, thoracic area 12.5%, 80% reduction: dorsal region 25%). Similarly, the female group, with a larger sample size (25 participants), demonstrated significant reductions (100% reduction: facial region 36%, thoracic area 24%, 80% reduction: dorsal area 4%). Overall, improvements were evident in all participants, with none falling below a 30% reduction, indicating remarkable outcomes after one month of vitamin D cream use. Numerous factors contribute to the onset of inflammatory acne, with this study specifically highlighting vitamin D deficiency in the blood. Other indications include the occurrence of polycystic ovaries and reduced thyroid function in women, heightened stress, and prostate issues in men. Reduced or deficient vitamin D levels may be associated with further immune system suppression, activating the aforementioned factors. This research marks a significant stride in uncovering the manifold health benefits of vitamin D.</p> <p>&nbsp;</p> <p><strong>Keywords: </strong><em>acne, vitamin D, participants</em></p> Lana Lekic Bojan Pavlovic Copyright (c) 2024 International Journal of Medical Science and Clinical Invention https://creativecommons.org/licenses/by/4.0/ 2024-04-12 2024-04-12 11 04 7087 7091 10.18535/ijmsci/v11i4.02